Clinical Trials · NCT00664456
Luteinizing Hormone-Releasing Hormone Agonist Therapy and Iodine I 125 Implant in Treating Patients With Previously Untreated Prostate Cancer
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
- Enrollment
- 421
- Start date
- Apr 2008
- Locations
- 1 site, Japan
- Primary endpoint
- Biochemical progression-free survival (bPFS)